RR
Raveendran Ratheesh
About Raveendran Ratheesh
Data last updated:
Raveendran Ratheesh is a Managing Director at Eysys Pharmaceutical Private Limited (since 2019). The companies operate in Pharma and E-Commerce. Eysys Pharmaceutical Private Limited reported revenue of ₹127 Cr (FY 2024). Earlier, Raveendran Ratheesh was a Director at Rx365 Technologies Private Limited (2018–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 07 Aug 2019 | 2019 | ₹127 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Apr 2018 | 2018 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Raveendran Ratheesh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mani Deepakkumar | 08532418 | Eysys Pharmaceutical Private Limited | Director |
| Manian Jayakrishnan | 08532419 | Eysys Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raveendran Ratheesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raveendran Ratheesh
Raveendran Ratheesh currently holds 1 directorship: Eysys Pharmaceutical Private Limited (Managing Director, since 07 Aug 2019, revenue ₹127 Cr (FY 2024)).
Raveendran Ratheesh was first appointed on 19 Apr 2018 as Director at Rx365 Technologies Private Limited. The most recent appointment on record is 07 Aug 2019 at Eysys Pharmaceutical Private Limited.
Raveendran Ratheesh held 1 earlier board appointment: Rx365 Technologies Private Limited (Director, 19 Apr 2018 to 19 Feb 2019).
The current boards of Raveendran Ratheesh's companies include Mani Deepakkumar (Eysys Pharmaceutical Private Limited), Manian Jayakrishnan (Eysys Pharmaceutical Private Limited).